Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic–Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome
Thyroid® · 01.08.2024 · 34 (8) · 1038-1046
DOI: 10.1089/thy.2024.0132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, erschienen am 01.08.2024. Verfasst von Pryscilla Moreira de Souza Domingues-Hajj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, Brazil. Hauptthemen laut MEDLINE: Insulin Resistance, Thyroid Hormone Resistance Syndrome, Cardiometabolic Risk Factors, Glucose Clamp Technique. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, Brazil.
Zitieren
APA
Domingues-Hajj, P. M. S., Gomes, P. M., Magalhães, P. K. R., & Maciel, L. M. Z. (2024). Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic–Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome. Thyroid®, 34(8), 1038-1046. https://doi.org/10.1089/thy.2024.0132
Vancouver
Domingues-Hajj PMS, Gomes PM, Magalhães PKR, Maciel LMZ. Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic–Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome. Thyroid®. 2024;34(8):1038-1046. doi:10.1089/thy.2024.0132
BibTeX
@article{DominguesHajj2024,
author = {Domingues-Hajj, Pryscilla Moreira de Souza and Gomes, Patrícia Moreira and Magalhães, Patrícia Künzle Ribeiro and Maciel, Léa Maria Zanini},
title = {Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic–Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome},
journal = {Thyroid®},
year = {2024},
volume = {34},
number = {8},
pages = {1038--1046},
doi = {10.1089/thy.2024.0132}
}
EUVIMED